Document is current
Any future updates will be listed below
-
Authors
Egan, Brent M. https://orcid.org/0000-0002-1470-5875
Lackland, Daniel T. https://orcid.org/0000-0001-5733-6283
Sutherland, Susan E.
Rakotz, Michael K.
Williams, Janet
Commodore-Mensah, Yvonne
Jones, Daniel W.
Kjeldsen, Sverre-Erik
Campbell, Norm R. C. https://orcid.org/0000-0002-1093-4742
Parati, Gianfranco https://orcid.org/0000-0001-9402-7439
He, Feng J.
MacGregor, Graham A.
Weber, Michael A. https://orcid.org/0000-0002-8504-0831
Whelton, Paul K. https://orcid.org/0000-0002-2225-383X
- License Information
-
More Information
Article History
Received: 7 November 2024
Revised: 14 January 2025
Accepted: 6 February 2025
First Online: 21 March 2025
Competing interests
: BME, none; DTL, none; SES, none; MKR, none; JW, none; YC-M, none; DWJ, none; SEK reports lecture honoraria from Emcure, Getz, Glenmark, J.B. Pharma, Merck Healthcare KGaA, and Vector-Intas in the past 3 years; NRCC, none; GP, none; FJH is an unpaid member of Action on Salt and World Action on Salt, Sugar and Health (WASSH); GAM is the unpaid Chair of Action on Salt, Action on Sugar, World Action on Salt, Sugar and Health (WASSH), and Blood Pressure UK; MAW, none; PKW, none.
